tebuconazole has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braeuning, A; Lasch, A; Lichtenstein, D; Marx-Stoelting, P | 1 |
| Braeuning, A; Buhrke, T; Knebel, C; Lampen, A; Marx-Stoelting, P; Süssmuth, R | 1 |
2 other study(ies) available for tebuconazole and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells.
Topics: Adverse Outcome Pathways; Carcinoma, Hepatocellular; Cell Line, Tumor; Dioxolanes; Dioxoles; Fatty Acids; Fatty Liver; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Models, Theoretical; Pesticides; Pyrroles; Triazoles; Triglycerides | 2021 |
Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines.
Topics: Carcinoma, Hepatocellular; Cell Line; Fatty Liver; Fungicides, Industrial; Gene Knockout Techniques; Hep G2 Cells; Humans; Liver Neoplasms; Pregnane X Receptor; Triazoles | 2019 |